- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
If $100G Cancer Drugs Worry You, Join Us! 'Cancer Drug Racket' Article, 'Morning Joe' Segment Draw Attention to Debate Over Balancing Care, Cost in Oncology
With the US Food and Drug Administration busier than ever with breakthrough and priority review designations, and the rise of genetic-based treatments offering new hope for patients and families, the pressure is on oncologists to push the limits in care. But if it costs $200,000 to extend life just a few weeks, does that make sense? Are doctors having that conversation? When they do, are patients hearing it? These are the very issues that will be on the table in Baltimore Nov. 14-15 when The American Journal of Managed Care convenes experts from the front line.
FOR IMMEDIATE RELEASE October 22, 2013
If $100G Cancer Drugs Worry You, Join Us!
‘Cancer Drug Racket’ Article, ‘Morning Joe’ Segment Draw Attention
to Debate Over Balancing Care, Cost in Oncology
Baltimore Meeting Nov. 14-15 to Bring Experts Together on How to Make Tough Calls
PLAINSBORO, N.J. — From the article in New York magazine that called some current therapies a “cancer drug racket,” to Dr. Zeke Emanuel’s appearance this week on MSNBC’s “Morning Joe,’ there is growing awareness of the tough decisions that doctors and health plan executives must make as both the breakthroughs and costs escalate in the world of cancer care.
With the US Food and Drug Administration busier than ever with “breakthrough” and “priority review” designations, and the rise of genetic-based treatments offering new hope for patients and families, the pressure is on oncologists to push the limits in care. But, as Emanuel explained on MSNBC, if it costs $200,000 to extend life just a few weeks, does that make sense? And, he explained further, are doctors having that conversation? When they do, are patients hearing it?
These are the very issues that will be on the table in Baltimore Nov. 14-15 when The American Journal of Managed Care convenes experts from the front lines — clinical and academic leaders, developers of life-saving therapies, and those who are transforming the way healthcare does business. For more information about the conference and a proposed agenda, please visit the web site at: http://www.ajmc.com/meetings/oncologycare13.
“Patient-Centered Oncology Care: Real World Perspectives” will take place November 14-15 at the Royal Sonesta Harbor Court, Baltimore. This two-day conference, which features an evening networking reception, will bring together key leaders in managed care and beyond. All will share how the goals of better care, savings and fair compensation can be achieved, even in the world of oncology.
Attend this conference if you want to know:
- How cancer care delivery will change under accountable care organizations (ACOs)
- How consumer voices will change the management of cancer care
- How to understand the balance between cost and quality in end-of-life care
- How pharmaceutical companies and insurers can work together
Credentialed media who wish to register for the conference must contact Nicole Beagin or Mary Caffrey at (609) 716-7777. A limited number of hotel rooms have been reserved, but members of the media must contact Nicole Beagin to hold a room at the conference rate.
Highlights on major speakers at the conference are attached.
CONTACT:
Nicole Beagin (609) 716-7777 x. 131
Mary Caffrey (609) 716-7777 x. 144
Follow us on @AJMC_Journal and @EBOncology
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease
November 20th 2024Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.
Read More
